Appointments at Teva, Codexis, Albemarle and BayBio – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Teva, Codexis, Albemarle and BayBio.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Teva, Codexis, Albemarle and BayBio.
Compugen has developed a computer-based, in silico system which can assist drug delivery research by identifying peptides that have the potential to penetrate cell membranes.
Indian CRO GVK Biosciences hopes new clinical pharmacology unit in Ahmedabad will help boost patient recruitment to meet growing demand for clinical trials in the region.
Prosonix’ new UMAX particle engineering technology is set to “revolutionise” the field of respiratory medicines, according to company CEO David Hipkiss.
US drug giant Pfizer will assess Tekimra Pharmaceuticals’s stable nucleic acid-lipid particle (SNALP) platform for the delivery of siRNA drugs.
Quintiles has relocated its global central laboratory in Japan to meet rising demand from the local market and US and European pharmas keen to include the country in their clinical trial network.